The Japanese Version of the Daily Record of Severity of Problems for Premenstrual Symptoms: Reliability and Validity Among the General Japanese Population
Takashi Takeda,Kana Yoshimi,Sayaka Kai,Fumi Inoue
DOI: https://doi.org/10.2147/ijwh.s450300
2024-02-26
International Journal of Women s Health
Abstract:Takashi Takeda, Kana Yoshimi, Sayaka Kai, Fumi Inoue Division of Women's Health, Research Institute of Traditional Asian Medicine, Kindai University, Osaka-Sayama, Osaka, Japan Correspondence: Takashi Takeda, Division of Women's Health, Research Institute of Traditional Asian Medicine, Kindai University, 377-2 Ohno-Higashi, Osaka-Sayama, Osaka, 589-8511, Japan, Tel +81-72-366-0221 (Ext. 3393), Fax +81-72-366-6661, Email Purpose: The validity and reliability of the Japanese version of the Daily Record of Severity of Problems (DRSP-J) have already been confirmed in a population with premenstrual symptoms. This study aimed to assess the validity and reliability of the DRSP-J in the general population. Patients and Methods: We analyzed data from 113 Japanese women with regular menstrual cycles who applied to participate in an ongoing study. Participants were recruited regardless of the severity of premenstrual symptoms, and their menstrual cycles were monitored using the DRSP-J for two cycles. Reliability was examined using Cronbach's α, a measure of internal consistency, and test-retest reliability. Structural validity was assessed using a principal component analysis (PCA). The Hospital Anxiety and Depression Scale (HADS) and EuroQol-5 Dimensions-5 Levels (EQ-5D-5L) were used to examine concurrent validity. The agreement between the clinical diagnoses based on the diagnostic criteria for premenstrual syndrome/premenstrual dysphoric disorder and that based on the DRSP-J score was examined using the kappa coefficient. Results: Cronbach's α for DRSP-J total score was 0.96. The DRSP-J total score showed high test-retest reliability. The PCA showed a two-factor model describing "Mood" and "Behavior/Physical" symptoms. The DRSP-J total score was highly correlated with the HADS total and EQ-5D-5L scores. The classification of "moderate to severe premenstrual syndrome" and "premenstrual dysphoric disorder" by clinical methods and the criteria based on the DRSP-J were in good agreement (kappa values = 0.78). Conclusion: The DRSP-J is a reliable and valid measure of premenstrual symptoms in the general Japanese population, including those with few or no symptoms. Keywords: premenstrual syndrome, premenstrual dysphoric disorder, psychometric testing, premenstrual symptom Premenstrual symptoms are characterized by a wide range of mood, behavioral, and physical symptoms limited to the luteal Phase 1,2 and affect the social, familial, and school lives of most women. Epidemiological studies have revealed that 80% to 90% of menstruating women exhibit premenstrual symptoms. 3 Premenstrual syndrome (PMS) is a pathological state of premenstrual symptoms, and a severe form of PMS is diagnosed as premenstrual dysphoric disorder (PMDD), primarily owing to its severe psychiatric symptoms. 4 Both the PMS diagnostic criteria of the American College of Obstetricians and Gynecologists (ACOG) and the PMDD diagnostic criteria of the American Psychiatric and Neurological Association require evaluation using a prospective symptom diary. 5 Both PMS and PMDD are viewed as premenstrual disorders (PMDs), a series of consecutive disorders. 6 The Daily Record of Severity of Problems (DRSP) was originally developed by Endicott to aid in the diagnosis of PMDD according to the Diagnostic and Statistical Manual of Mental Disorders (DSM) criteria. 7 The DRSP is a prospective daily charting tool used worldwide for the strict evaluation of PMDs. 8–10 The DRSP score has been used as the primary endpoint in clinical trials to evaluate the efficacy of serotonin reuptake inhibitors and drospirenone-containing oral contraceptives, which are globally recognized as the standard treatments for PMDs. 11–14 The DRSP was translated into Japanese after linguistic validation according to a general cross-cultural adaptation process for clinical trials, and a Japanese version of the DRSP (DRSP-J) was developed. 15–17 The DRSP-J has been systematically evaluated for its reliability and validity among participants in clinical trials of treatment for PMDs. 18 The psychometric characteristics of a survey instrument vary depending on the characteristics of the surveyed population. The reliability and validity of the original version of the DRSP were examined for both clinical trial participants and participants with a wide range of symptom severity, including those with few or no premenstrual symptoms. 7 The DRSP-J was considered insufficient compared to the original DRSP, as only clinical trial participants had been examined. Therefore, examining the psychological characteristics of the DRSP-J among the general female population is necessary. This study aimed to assess the val -Abstract Truncated-
obstetrics & gynecology